Literature DB >> 10692992

Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis.

C H Wang1, C T Yu, H C Lin, C Y Liu, H P Kuo.   

Abstract

SETTING: Alveolar macrophages (AM), a heterogeneous cell population, play a critical role in eliminating mycobacterial infections in collaboration with lymphocytes. Patients with diabetes mellitus (DM) show increased susceptibility to pulmonary tuberculosis (TB) infection. It is still uncertain whether there is a defect in T cell or AM activation in patients with DM against TB infection.
OBJECTIVE: To study the difference in activation status of AM and T cells between patients with TB + DM and TB alone.
METHOD: The heterogeneity of AM from 14 patients with TB + DM, 9 with TB alone, 10 normal subjects and 8 DM alone patients, was studied using Percoll density fractionation. The intracellular H2O2 production of AM before and after stimulation with phorbol myristate acetate (PMA) or F-Met-Leu-Phen (FMLP) was assayed by loading cells with 2',7'-dichlorofluorescin (DCFH) and analyzed by flow cytometry. Lymphocytes subsets (CD3, CD4, CD8) and their activation status (CD25) in bronchoalveolar lavage were also measured.
RESULTS: The proportion of the least dense AM (< 1,030 g/ml) and the magnitude of DCFH oxidation of AM was higher in TB patients than in normal subjects, regardless of DM. Patients with TB + DM had a significantly lower proportion of the least density AM fraction than TB alone patients, regardless of disease extent. Among TB patients, the proportion of the least dense AM was inversely correlated with the bacterial load on sputum and the disease extent on chest radiograph. Stimulation of AM with PMA or FMLP induced an increase in the hypodense AM subpopulations and enhanced intracellular H2O2 generation in patients with TB + DM and to a similar extent in normal subjects, but not in patients with TB alone. There was no significant difference in CD3 numbers, CD4/CD8 ratio, and CD25+ cells between patients with TB alone and TB + DM. The activation status of AM or T lymphocytes from DM alone patients was not significantly different from those from normal subjects.
CONCLUSION: Hypodense subpopulations of AM increase in active TB patients and are related to the disease severity as well as activation status of AM. AM in TB patients complicated with DM was less activated, and may be contributory to the susceptibility to mycobacterial infection.

Entities:  

Mesh:

Year:  1999        PMID: 10692992     DOI: 10.1054/tuld.1998.0167

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  28 in total

Review 1.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

2.  The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people.

Authors:  Roland F Dyck; Helena Klomp; Darcy D Marciniuk; Leonard Tan; Mary Rose Stang; Heather A Ward; Vernon H Hoeppner
Journal:  Can J Public Health       Date:  2007 Jan-Feb

Review 3.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

4.  Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

Authors:  Eun Hye Lee; Jung Mo Lee; Young Ae Kang; Ah Young Leem; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Song Yee Kim
Journal:  Lung       Date:  2017-02-09       Impact factor: 2.584

Review 5.  Diabetes and immunity to tuberculosis.

Authors:  Nuria Martinez; Hardy Kornfeld
Journal:  Eur J Immunol       Date:  2014-02-16       Impact factor: 5.532

6.  The effect of diabetic control status on the clinical features of pulmonary tuberculosis.

Authors:  S W Park; J W Shin; J Y Kim; I W Park; B W Choi; J C Choi; Y S Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

7.  Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.

Authors:  R L Hensel; R R Kempker; J Tapia; A Oladele; H M Blumberg; M J Magee
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

8.  Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Authors:  Omamah Alfarisi; Vidya Mave; Sanjay Gaikwad; Tushar Sahasrabudhe; Geetha Ramachandran; Hemanth Kumar; Nikhil Gupte; Vandana Kulkarni; Sona Deshmukh; Sachin Atre; Swapnil Raskar; Rahul Lokhande; Madhusudan Barthwal; Arjun Kakrani; Sandy Chon; Amita Gupta; Jonathan E Golub; Kelly E Dooley
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 9.  Impact of diabetes on the natural history of tuberculosis.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Diabetes Res Clin Pract       Date:  2014-07-14       Impact factor: 5.602

10.  Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.

Authors:  Kelly E Dooley; Tania Tang; Jonathan E Golub; Susan E Dorman; Wendy Cronin
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.